Target Price | $148.90 |
Price | $133.70 |
Potential | 11.37% |
Number of Estimates | 31 |
31 Analysts have issued a price target Arm 2025 . The average Arm target price is $148.90. This is 11.37% higher than the current stock price. The highest price target is $200.00 49.59% , the lowest is $80.00 40.16% . | |
A rating was issued by 41 analysts: 24 Analysts recommend Arm to buy, 13 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Arm stock has an average upside potential 2025 of 11.37% . Most analysts recommend the Arm stock at Purchase. |
32 Analysts have issued a sales forecast Arm 2025 . The average Arm sales estimate is $3.9b . This is 11.72% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $4.1b 15.64% , the lowest is $3.7b 3.42% .
This results in the following potential growth metrics:
2024 | $3.2b | 20.68% |
---|---|---|
2025 | $3.9b | 22.15% |
2026 | $4.9b | 25.04% |
2027 | $6.0b | 22.47% |
2028 | $6.8b | 12.10% |
2029 | $8.0b | 18.61% |
16 Analysts have issued an Arm EBITDA forecast 2025. The average Arm EBITDA estimate is $2.0b . This is 244.27% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.1b 261.08% , the lowest is $1.8b 211.17% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $261m | 69.23% |
---|---|---|
2025 | $2.0b | 655.82% |
2026 | $2.6b | 34.24% |
2027 | $3.5b | 32.87% |
2028 | $4.0b | 14.50% |
2029 | $5.7b | 40.78% |
2024 | 8.07% | 74.50% |
---|---|---|
2025 | 49.95% | 518.73% |
2026 | 53.63% | 7.37% |
2027 | 58.18% | 8.48% |
2028 | 59.42% | 2.13% |
2029 | 70.53% | 18.70% |
19 Arm Analysts have issued a net profit forecast 2025. The average Arm net profit estimate is $876m . This is 38.99% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.5b 130.00% , the lowest is $736m 16.67% .
This results in the following potential growth metrics and future Net Margins:
2024 | $305m | 43.14% |
---|---|---|
2025 | $876m | 187.57% |
2026 | $1.3b | 51.33% |
2027 | $1.8b | 39.05% |
2028 | $2.5b | 37.91% |
2029 | $3.2b | 24.38% |
2024 | 9.43% | 52.88% |
---|---|---|
2025 | 22.19% | 135.38% |
2026 | 26.86% | 21.05% |
2027 | 30.49% | 13.51% |
2028 | 37.51% | 23.02% |
2029 | 39.34% | 4.88% |
19 Analysts have issued a Arm forecast for earnings per share. The average Arm <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $0.83 . This is 38.33% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $1.38 130.00% , the lowest is $0.70 16.67% .
This results in the following potential growth metrics and future valuations:
2024 | $0.29 | 43.14% |
---|---|---|
2025 | $0.83 | 186.21% |
2026 | $1.26 | 51.81% |
2027 | $1.75 | 38.89% |
2028 | $2.42 | 38.29% |
2029 | $3.01 | 24.38% |
Current | ||
---|---|---|
2025 | 160.32 | 27.57% |
2026 | 105.94 | 33.92% |
2027 | 76.19 | 28.08% |
2028 | 55.25 | 27.48% |
2029 | 44.42 | 19.60% |
Based on analysts' sales estimates for 2025, the Arm stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 35.05 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 35.58 .
This results in the following potential growth metrics and future valuations:
Current | 39.16 | |
---|---|---|
2025 | 35.05 | 10.49% |
2026 | 28.03 | 20.03% |
2027 | 22.89 | 18.35% |
2028 | 20.42 | 10.79% |
2029 | 17.21 | 15.69% |
Current | ||
---|---|---|
2025 | 35.58 | 10.49% |
2026 | 28.45 | 20.03% |
2027 | 23.23 | 18.35% |
2028 | 20.73 | 10.79% |
2029 | 17.47 | 15.69% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.